
Recent analyst recommendations highlight significant upside potential for midcap stocks, with multiple companies receiving 'strong buy' and 'buy' ratings from market experts. According to The Economic Times, these stocks offer upside potential of over 25%, making them attractive investment opportunities despite current market uncertainties. The recommendations come amid ongoing institutional buying patterns, with both Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) raising their stakes across various midcap segments, indicating strong institutional confidence in these growth stories.
Lenskart, the global consumer eyewear brand with approximately 3,459 stores across India, emerged as the standout performer with significant institutional interest. The company has outlined a mid to long-term roadmap to scale to 10,000 stores in India alone, presenting substantial growth opportunities. FIIs increased their stake from 12.76% to 18.26% while DIIs raised their holdings from 23.56% to 26.81% during the quarter. Mutual funds increased their exposure from 12.20% to 15.91%, with promoters maintaining approximately 17.5% and public holding declining from 45.73% to 36.99%. The company, which listed in November 2025, has been actively expanding since pre-IPO shareholders' six-month lock-in ended in May 2026.
Beyond Lenskart, the September 2026 quarter showed consistent institutional buying across multiple sectors. Premier Polyfilm recorded the fastest revenue growth among the four companies, with revenue increasing 35.1% to ₹879.2 million in Q1 FY27. The company's operating profit grew 40.1% to ₹135.2 million, while operating profit margin improved from 14.8% to 15.4%, an expansion of 55 basis points. Net profit increased 51.3% to ₹90.8 million, with net profit margin rising from 9.2% to 10.3%. The company manufactures flexible PVC vinyl flooring and PVC sheets, with recent growth supported by additional production capacity following new plant commissioning.
Jagsonpal Pharmaceuticals showed strong performance with revenue growing 8.8% to ₹822.3 million and operating profit increasing 21.3% to ₹172.4 million, with operating profit margin expanding from 18.8% to 21.0%. Net profit rose 22.1% to ₹131.9 million with net profit margin improving from 14.3% to 16.0%. Prataap Snacks reported modest growth with revenue increasing 19.8% to ₹4,925 million but faced margin pressure, with operating profit margin declining from 4.4% to 4.1% due to higher raw material costs and increased competition. The company's store count expansion strategy aligns with the broader institutional interest in midcap growth stories.
While the September 2026 quarter's institutional buying patterns indicate strong growth potential in these midcap stocks, investors should view this activity as institutions agreeing to hold large blocks at current prices rather than a market verdict. The key factors for investors researching these stocks include sustainable earnings growth, margin stability, balance-sheet strength and valuation. The Q2 FY27 results present different growth stories, with Lenskart's expansion potential, Premier Polyfilm's revenue momentum, and Jagsonpal Pharmaceuticals' margin expansion offering varied investment opportunities. The large addressable market gaps identified by companies like Lenskart, with over 6,100 pin codes still without a single store, provide substantial growth headroom for institutional backing, making these stocks particularly attractive for investors seeking exposure to India's expanding consumer markets.